NEBO-178

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNEBO-178
Drug Alias NameNEBO-178
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors modulatorsSigma opioid receptor antagonists
TargetsSigma opioid receptorEstrogen receptors
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesStegram
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStegram
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A